当前位置: X-MOL 学术Clin. Gastroenterol. Hepatol. › 论文详情
Clinical and Pathological Characterization of Lynch-Like Syndrome.
Clinical Gastroenterology and Hepatology ( IF 7.958 ) Pub Date : 2019-06-17 , DOI: 10.1016/j.cgh.2019.06.012
María Dolores Picó,Adela Castillejo,Óscar Murcia,Mar Giner-Calabuig,Miren Alustiza,Ariadna Sánchez,Leticia Moreira,María Pellise,Antoni Castells,Marta Carrillo-Palau,Teresa Ramon Y Cajal,Alexandra Gisbert-Beamud,Gemma Llort,Carmen Yagüe,Adriá López-Fernández,Cristina Alvarez-Urturi,Joaquin Cubiella,Laura Rivas,Daniel Rodríguez-Alcalde,Maite Herraiz,Catalina Garau,Carlos Dolz,Luis Bujanda,Lucia Cid,Carmen Povés,Marta Garzon,Inmaculada Salces,Marta Ponce,Luís Hernández-Villalba,Cristina Alenda,Francesc Balaguer,Jose-Luis Soto,Rodrigo Jover

BACKGROUND & AIMS Lynch syndrome is characterized by DNA mismatch repair (MMR) deficiency. Some patients with suspected Lynch syndrome have DNA MMR deficiencies but no detectable mutations in genes that encode MMR proteins-this is called Lynch-like syndrome (LLS). There is no consensus on management of patients with LLS. We collected data from a large series of patients with LLS to identify clinical and pathology features. METHODS We collected data from a nationwide-registry of patients with colorectal cancer (CRC) in Spain. We identified patients whose colorectal tumors had loss of MSH2, MSH6, PMS2, or MLH1 (based on immunohistochemistry), without the mutation encoding V600E in BRAF (detected by real-time PCR), and/or no methylation at MLH1 (determined by methylation-specific multiplex ligation-dependent probe amplification), and no pathogenic mutations in MMR genes, BRAF, or EPCAM (determined by DNA sequencing). These patients were considered to have LLS. We collected data on demographic, clinical, and pathology features and family history of neoplasms. The χ2 test was used to analyze the association between qualitative variables, followed by the Fisher exact test and the Student t test or the Mann-Whitney test for quantitative variables. RESULTS We identified 160 patients with LLS; their mean age at diagnosis of CRC was 55 years and 66 patients were female (41%). The Amsterdam I and II criteria for Lynch syndrome were fulfilled by 11% of cases and the revised Bethesda guideline criteria by 65% of cases. Of the patients with LLS, 24% were identified in universal screening. There were no proportional differences in sex, indication for colonoscopy, immunohistochemistry, pathology findings, or personal history of CRC or other Lynch syndrome-related tumors between patients who met the Amsterdam and/or Bethesda criteria for Lynch syndrome and patients identified in universal screening for Lynch syndrome, without a family history of CRC. CONCLUSIONS Patients with LLS have homogeneous clinical, demographic, and pathology characteristics, regardless of family history of CRC.
更新日期:2020-01-13

 

全部期刊列表>>
全球疫情及响应:BMC Medicine专题征稿
欢迎探索2019年最具下载量的化学论文
新版X-MOL期刊搜索和高级搜索功能介绍
化学材料学全球高引用
ACS材料视界
南方科技大学
x-mol收录
南方科技大学
自然科研论文编辑服务
上海交通大学彭文杰
中国科学院长春应化所于聪-4-8
武汉工程大学
课题组网站
X-MOL
深圳大学二维材料实验室张晗
中山大学化学工程与技术学院
试剂库存
天合科研
down
wechat
bug